Fat in the belly may promote inflammation leading to diabetes and heart disease, say researchers.
Read More »Diabetes In Control
Replacing Red Meat With Soy Improves Metabolic Syndrome
Soy as a replacement for red meat in a DASH eating plan had beneficial effects on features of the metabolic syndrome, soy-nut being more effective than soy-protein.
Read More »New Test Predicts Diabetic Nephropathy
Urine proteomic profiling can predict the development of diabetic nephropathy in type 2 diabetic patients with normoalbuminuria well before the condition arises, according to a new report
Read More »‘Enviga’ Soda Falsely Advertised Negative Calories
A new soda claiming it reduces calories was doubted to be effective and now a public nutrition and health advocacy group is suing over false advertising. The soda, a caffeinated green tea-flavored soda conceived jointly between Coca-Cola Co. and Nestlé S.A. of Switzerland.
Read More »Bowl of Wholegrain Cereal Daily Reduces Risk of Heart Failure by 27%
“The Physicians’ Health Study shows that even in a population with overall healthy behavior, it is possible to see less heart failure in those who eat a wholegrain cereal breakfast,”
Read More »Diabetes Risk Factors Develop Earlier in Women
The “diabetes clock” may start ticking in women years in advance of a medical diagnosis of the disease, new research has shown.
Read More »Tighter Control in Hospitals Provided Shorter Stays
Protocol-driven insulin therapy on the medical-surgical wards resulted in better glucose control, as compared to individualized management in patients with diabetic foot ulcers. As a result, shorter hospital stay may be possible.
Read More »Fructose Syrup-Obesity Link Mechanism Found
Scientists studying the effects of ingesting fructose syrup have reported a possible mechanism that may explain the alleged link between rising obesity and sweetened beverages.
Read More »New Analysis Details Cardiovascular Protective Benefits of Carvedilol In Heart Failure Patients
Patients with heart failure who received the heart medication carvedilol suffered fewer heart attacks and strokes and were less likely to die of these and other vascular events than patients prescribed another beta blocker, metoprolol tartrate.
Read More »Diamyd Begins Phase III Clinical Trials For Type 1 Diabetes
Diamyd Medical AB announced today details of its Phase III clinical protocol and plans in the US for Diamyd®, the company’s lead drug candidate for the treatment autoimmune diabetes, type 1 diabetes and Latent Autoimmune Diabetes of Adults (LADA)
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.